Acteoside Helps Treat Diabetic Retinopathy by Reducing Müller Cell Overgrowth
Author Information
Author(s): Xi Xiaoting, Liu Xiaolei, Chen Qianbo, Ma Jia, Wang Xuewei, Gui Yufei, Zhang Yuxin, Li Yan
Primary Institution: The First Affiliated Hospital of Kunming Medical University, Kunming, China
Hypothesis
ACT is able to alleviate the progression of DR by inhibiting the reactive proliferation of Müller cells via the Kir4.1 channel.
Conclusion
ACT inhibits Müller cell reactive proliferation and alleviates diabetic retinopathy by regulating TXNIP and mediating the expression of Kir4.1 channels in a PI3K/Akt-dependent manner.
Supporting Evidence
- ACT treatment improved retinal structure and reduced hemangiomas in diabetic rats.
- TXNIP expression was significantly upregulated in diabetic retinopathy models.
- ACT treatment inhibited the proliferation and migration of Müller cells.
Takeaway
This study shows that a natural compound called acteoside can help treat a serious eye problem caused by diabetes by stopping certain cells in the eye from growing too much.
Methodology
The study involved cell culture experiments with Müller RMC-1 cells and animal models of diabetic retinopathy, using various treatments and assays to measure cell proliferation, migration, and protein expression.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website